Skip to main content
. Author manuscript; available in PMC: 2011 Sep 1.
Published in final edited form as: Aliment Pharmacol Ther. 2010 Jul 22;32(6):738–755. doi: 10.1111/j.1365-2036.2010.04409.x

Table 3.

Relative risk (RR) of IBS symptoms in women versus men in both the general and IBS patient populations

General Population IBS Only
RR favoring women (95% CI) N of studies Heterogeneity RR favoring women (95% CI) N of studies Heterogeneity
IBS Diagnostic Symptoms
Pain 1.12 (1.02,1.22)* 5 P<0.001 N/A 1
Pain relieved with defecation 1.13 (0.97,1.31) 6 P<0.001 1.00 (0.80,1.25) 5 P=0.012
Pain associated with change in frequency 1.08 (1.03,1.14)* 6 P=0.005 N/A 1
Pain associated with change in form 1.12 (1.02,1.23)* 6 P<0.001 0.96 (0.82,1.12) 4 P=0.69
Supportive Symptoms
Distension N/A 2 1.29 (1.06,1.56)* 5 P=0.002
Bloating 1.12 (1.01,1.25)* 9 P<0.001 1.37 (1.16,1.61)* 6 P=0.028
Incomplete Evacuation 1.03 (0.93,1.13) 6 P<0.001 1.15 (0.97,1.37) 7 P=0.300
Infrequent stools 1.06 (0.99,1.14) 5 P<0.001 1.13 (1.08,1.18)* 6 P=0.387
Lumpy/Hard stools 0.98 (0.88,1.10) 4 P<0.001 1.21 (1.08,1.36)* 5 P=0.089
Straining 1.12 (1.03,1.23)* 4 P<0.001 1.01 (0.93,1.09) 5 P=0.284
Mucus 1.02 (0.97,1.07) 5 P<0.001 1.07 (0.96,1.19) 8 P=0.002
Urgency 1.02 (0.93,1.11) 4 P<0.001 1.04 (0.95,1.15) 6 P=0.249
Loose/Watery stools 0.97 (0.92,1.01) 5 P=0.002 0.84 (0.75,0.94)* 5 P=0.420
Frequent stools 1.00 (0.98,1.01) 4 P=0.635 0.88 (0.80,0.96)* 5 P=0.014

Abbreviations: RR: relative risk; CI: confidence interval; N= number; N/A: Not applicable due to insufficient number of studies to perform meta-analysis.

*

P < 0.05